Successful treatment on an out-patient basis of a patient with Down's syndrome and disseminated testicular seminoma

Netherlands Journal of Medicine

Volumn 48, Issue 3, 1996, Pages 89-91

  Sleijfer, S ^a   Schraffordt Koops, H ^a   Van Der Graaf, W T A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chemotherapy; Down's syndrome; Testicular cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ONDANSETRON; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW SUSPENSION; CANCER CHEMOTHERAPY; CASE REPORT; DOWN SYNDROME; HUMAN; LEUKOPENIA; MALE; NAUSEA; OUTPATIENT; SEMINOMA; TESTIS CANCER; THROMBOCYTOPENIA;

EID: 0029962951     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: 10.1016/0300-2977(95)00058-5     Document Type: Article

References (15)

1. Peckham M. Testicular cancer. Rev Oncol 1988;1:439-53.
2. Thompson JM, Thompson DD. Male fertility and the undescended testis in Down syndrome. Postgrad Med 1988;84:299-303.
3. Baird PA, Sadovnich AD. Life expectancy in Down's syndrome. J Pediatr 1987;110:849-54.
4. Braun DL, Green MD, Rausen AR et al. Down's syndrome and testicular cancer. A possible association. Am J Pediatr Hematol Oncol 1985;7:208-211.
5. Dexeus FH, Logothetis CJ, Chong C, Sells A, Ogden S. Genetic abnormalities in men with germ cell tumors. J Urol 1988;140:80-84.
6. Kamidono S, Takada K, Ischigami J, Furumoto M, Urano Y. Giant seminoma of undescended testis in Down syndrome. Urology 1985;25:637-640.
7. Sasagawa I, Kazama T, Umeda K, Kohno T, Katayama T, Miwa A. Down's syndrome associated with seminoma. Urol Int 1986;41:238-240.
8. Narod SA, Stiller C, Lenoir GM. An estimate of the heritable fraction of childhood cancer. Br J Cancer 1991;63:993-999.
9. Sasagawa I, Nakada T, Hashimoto T et al. Hormone profiles and contralateral testicular histology in Down's syndrome with unilateral testicular tumor. Arch Androl 1993;30:93-98.
10. Mencel PJ, Motzer RJ, Mazumdar M, Vlamis V, Bajorin DF, Bosl GJ. Advanced seminoma: treatment results, survival and prognostic factors in 142 patients. J Clin Oncol 1994;12:120-126.
11. Horwich A, Sleijfer D, Fossa S et al. A trial of carboplatin-based combination chemotherapy in good prognosis metastatic testicular non seminoma. Proc Am Soc Clin Oncol 1994;13:231(Abstract 709).
12. Horwich A, Dearnaley DP, Duchesne GM, Williams M, Brada M, Peckham MJ. Simple non-toxic treatment of advanced metastatic seminoma with carboplatin. J Clin Oncol 1989;7:1150-1156.
13. Logothetis CJ, Samuels ML, Ogden SL, Dexeus FH, Chong CDK. Cyclophosphamide and sequential cisplatin for advanced seminoma: long term follow up in 52 patients. J Urol 1987;138:789-794.
14. Wettlaufer JN, Feiner AS, Robinson WA. Vincristine, cisplatin and bleomycin with surgery in the management of advanced metastatic non-seminomatous testis tumors. Cancer 1984;53:203-209.
15. Schultz SM, Einhorn LH, Conces DJ, Williams SD, Loehrer PJ. Management of postchemotherapy residual mass in patients with advanced seminoma: Indiana University experience. J Clin Oncol 1989;7:1497-1503.